Insider trade

Director sold ~$243K of BRKR shares in the open market

Traded Nov 6, 2025 · Filed Nov 10, 2025

Why it stands out

A board member of Bruker sold $243K of Bruker shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$243,087

Shares × reported transaction price

Timing vs results

3 days after results of Nov 3, 2025, 67 days before results of Jan 12, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+2.2%	−3.4%	+5.6%
30 days	+11.1%	+0.9%	+10.2%
90 days	+0.9%	+1.6%	−0.7%
180 days	+3.7%	+8.2%	−4.5%

Past results only. Not a forecast.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.0001 to $39.0101, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.